Imfinzi Archives -

AZ takes aim at BMS’ lead in neoadjuvant NSCLC

Phil Taylor AstraZeneca, Bristol-Myers Squibb, Imfinzi, immuno-oncology, Keytruda, Merck & Co, Non-small cell lung cancer, Oncology, Opdivo 0 Comment

Just weeks after Bristol-Myers Squibb claimed an FDA green light for Opdivo as a neoadjuvant therapy for non-small

AZ takes aim at BMS’ lead in neoadjuvant NSCLC

https://pharmaphorum.com/news/az-takes-aim-at-bms-lead-in-neoadjuvant-nsclc/

Market Access/ News/ News/ News/ Oncology

AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer

Phil Taylor AstraZeneca, biliary tract cancer, Imfinzi, immuno-oncology, Oncology 0 Comment

The FDA has kicked off a priority review of AstraZeneca’s checkpoint inhibitor Imfinzi for biliary tract cancer (BTC),

AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer

https://pharmaphorum.com/news/az-eyes-q3-fda-decision-for-imfinzi-in-biliary-tract-cancer/

News/ News/ Oncology

AstraZeneca’s Imfinzi fails in cervical cancer bid

Phil Taylor AstraZeneca, cervical cancer, Imfinzi, immuno-oncology, Keytruda, Merck & Co, Oncology 0 Comment

AstraZeneca’s hopes of developing its PD-L1 inhibitor Imfinzi for cervical cancer have been hit by a failed phase

AstraZeneca’s Imfinzi fails in cervical cancer bid

https://pharmaphorum.com/news/astrazenecas-imfinzi-fails-in-cervical-cancer-bid/

News/ News/ Oncology

AZ’s Imfinzi is first immunotherapy to raise survival in biliary tract cancer

Phil Taylor AstraZeneca, biliary tract cancer, Imfinzi, immuno-oncology, Oncology 0 Comment

AstraZeneca’s checkpoint inhibitor Imfinzi has become the first cancer immunotherapy to improve survival in previously-untreated patients with biliary

AZ’s Imfinzi is first immunotherapy to raise survival in biliary tract cancer

https://pharmaphorum.com/news/azs-imfinzi-is-first-immunotherapy-to-raise-survival-in-biliary-tract-cancer/

News/ News/ Sales and Marketing

AZ’s COVID-19 jab sales top $1.2bn, but come at a loss

Phil Taylor AstraZeneca, coronavirus, COVID-19, COVID-19 vaccine, Farxiga, Financial, Imfinzi, Lynparza, Tagrisso 0 Comment

AstraZeneca said this morning that it has made $1.2 billion in sales from its COVID-19 vaccine Vaxzevria in

AZ’s COVID-19 jab sales top $1.2bn, but come at a loss

https://pharmaphorum.com/news/azs-covid-19-jab-sales-top-1-2bn-but-come-at-a-loss/

News/ News/ Oncology

AstraZeneca bags Imfinzi okay in big Chinese lung cancer market

Phil Taylor AstraZeneca, China, Imfinzi, Roche, small cell lung cancer, Tecentriq 0 Comment

China has approved AstraZeneca’s PD-1/PD-L1 inhibitor Imfinzi to treat small-cell lung cancer (SCLC), an aggressive form of the

AstraZeneca bags Imfinzi okay in big Chinese lung cancer market

https://pharmaphorum.com/news/astrazeneca-bags-imfinzi-okay-in-big-chinese-lung-cancer-market/

Market Access/ News/ News

AZ withdraws Imfinzi in US bladder cancer use after trial failure

Richard Staines AstraZeneca, bladder cancer, cancer, Imfinzi 0 Comment

AstraZeneca has suffered a setback after it voluntarily withdrew its cancer immunotherapy Imfinzi (durvalumab) in a bladder cancer

AZ withdraws Imfinzi in US bladder cancer use after trial failure

https://pharmaphorum.com/news/az-withdraws-imfinzi-in-us-bladder-cancer-use-after-trial-setback/

News/ News/ News/ Oncology/ R&D

AZ nabs a positive study for Imfinzi plus tremelimumab in liver cancer

Phil Taylor ASCO 2020, AstraZeneca, Imfinzi, immuno-oncology, Liver cancer, Oncology, tremelimumab 0 Comment

After a long run of trial disappointments, AstraZeneca is celebrating a win for its immuno-oncology combination of Imfinzi

AZ nabs a positive study for Imfinzi plus tremelimumab in liver cancer

https://pharmaphorum.com/news/astrazeneca-imfinzi-tremelimumab-liver-cancer-asco-2020/

News/ News/ News/ Oncology/ R&D

FDA approves AZ Imfinzi in new lung cancer use

Richard Staines AstraZeneca, chronic kidney disease, Diabetes, Farxiga, Imfinzi, lung cancer 0 Comment

AstraZeneca has reported a double win after the FDA approved its Imfinzi for a form of lung cancer,

FDA approves AZ Imfinzi in new lung cancer use

https://pharmaphorum.com/news/fda-approves-az-imfinzi-in-new-lung-cancer-use/

Trending

Imfinzi

Login